PTC
CABA icon

Private Trust Company’s Cabaletta Bio CABA Stock Holding History

Private Trust Company’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-712
Closed -$1.62K – 2481
2024
Q4 		$1.62K Sell
712
-160
-18% -$562 ﹤0.01% 2197
2024
Q3 		$4.12K Buy
872
+334
+62% +$1.93K ﹤0.01% 2009
2024
Q2 		$4.02K Hold
538
– – ﹤0.01% 2002
2024
Q1 		$9.18K Sell
538
-115
-18% -$2.47K ﹤0.01% 1691
2023
Q4 		$14.8K Buy
653
+156
+31% +$2.62K ﹤0.01% 1515
2023
Q3 		$7.56K Hold
497
– – ﹤0.01% 1703
2023
Q2 		$6.42K Buy
497
+129
+35% +$1.4K ﹤0.01% 1790
2023
Q1 		$3.04K Buy
+368
New +$3.44K ﹤0.01% 1996

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Private Trust Company's CABA Position: Q1 2025 in Review

Private Trust Company sold out of Cabaletta Bio (CABA) in Q1 2025, closing a stake of 712 shares — an estimated $1.62K sold.

Private Trust Company first reported a position in CABA in Q1 2023 and held it in 8 quarters. The position peaked at $14.8K in Q4 2023. 92 funds tracked by Wall St. Rank hold CABA as of Q1 2025.

  • Private Trust Company reported no remaining Cabaletta Bio position as of Q1 2025 after selling out during the quarter.
  • Private Trust Company sold 712 Cabaletta Bio shares in Q1 2025, an estimated $1.62K.
  • Private Trust Company first reported a position in Cabaletta Bio in Q1 2023 and held it in 8 quarters.
  • Private Trust Company's Cabaletta Bio position peaked at $14.8K in Q4 2023.
  • 92 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2025.

Based on Private Trust Company's 13F filing for Q1 2025, filed 28 Apr 2025.